JB
KALA icon

Julian Baker’s KALA BIO KALA Stock Holding History

Julian Baker’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,081
Closed -$1M – 88
2025
Q4 		$1M Buy
36,081
+16,379
+83% +$733K 0.01% 82
2025
Q3 		$1.51M Sell
19,702
-4,336
-18% -$2.15M 0.01% 83
2025
Q2 		$5.72M Hold
24,038
– – 0.06% 65
2025
Q1 		$6.89M Hold
24,038
– – 0.08% 54
2024
Q4 		$8.34M Buy
24,038
+6,211
+35% +$1.96M 0.09% 57
2024
Q3 		$5.08M Hold
17,827
– – 0.05% 68
2024
Q2 		$6.32M Buy
17,827
+12,495
+234% +$4.13M 0.08% 58
2024
Q1 		$2.12M Hold
5,332
– – 0.03% 73
2023
Q4 		$1.87M Hold
5,332
– – 0.02% 73
2023
Q3 		$2.37M Buy
5,332
+3,008
+129% +$1.97M 0.01% 81
2023
Q2 		$1.7M Buy
2,324
+788
+51% +$612K 0.01% 98
2023
Q1 		$1.16M Hold
1,536
– – 0.01% 97
2022
Q4 		$2.93M Buy
+1,536
New +$608K 0.02% 89

Other funds holding KALA

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Julian Baker's KALA Position: Q1 2026 in Review

Julian Baker sold out of KALA BIO (KALA) in Q1 2026, closing a stake of 36,081 shares — an estimated $1M sold.

Julian Baker first reported a position in KALA in Q4 2022 and held it in 13 quarters. The position peaked at $8.34M in Q4 2024. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • Julian Baker reported no remaining KALA BIO position as of Q1 2026 after selling out during the quarter.
  • Julian Baker sold 36,081 KALA BIO shares in Q1 2026, an estimated $1M.
  • Julian Baker first reported a position in KALA BIO in Q4 2022 and held it in 13 quarters.
  • Julian Baker's KALA BIO position peaked at $8.34M in Q4 2024.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Baker Bros. Advisors's 13F filing for Q1 2026, filed 15 May 2026.